Central Nervous specific protein (S100-β) Test Kit (Fluorescence Immunochromatographic Assay)
- Risk class
- IVD General
- CND nomenclatures code
- W0102019099
- Implantable
- No
- Reusable
- No
- Measuring function
- No
- Primary DI
- D-K90411-042PD
- Basic UDI
- B-K90411-042PD
- Version date
- July 04, 2022
- Manufacturer last update
- August 16, 2021
- Active status
- No
- Manufacturer name
- SHENZHEN REETOO BIOTECHNOLOGY CO., LTD
- Country
- China
- Country type
- NON_EU
- Address
- F406, Building F, Huafeng International Robot Industrial Park, Hangcheng Avenue, Nanchang Community, Xixiang Street, Bao'an District Not applicable Shenzhen
- service@reetoo.com.cn
- SRN
- NL-AR-000000444
- Country
- Netherlands
- Address
- Treubstraat 1 Rijswijk
- ar@umedwings.eu
- Telephone
- +31 (0) 642758955
- Competent authority
- DE/CA05 - Behorde fur Justiz und Verbraucherschutz
- Applicable legislation
- IVDD (Directive 98/79/EC on in vitro Diagnostic Medical Devices)
- Placed on the market
- Italy
- Human tissues
- No
- Animal tissues
- Yes
SPECIFIC PROTEINS - OTHER
Access comprehensive regulatory information for Central Nervous specific protein (S100-β) Test Kit (Fluorescence Immunochromatographic Assay) in the European Union medical device market through Pure Global AI's free database. This IVD General device is registered with EU EUDAMED under Primary DI D-K90411-042PD and manufactured by SHENZHEN REETOO BIOTECHNOLOGY CO., LTD in China.
This page provides complete registration details including manufacturer information, authorized representative details, competent authority (DE/CA05 - Behorde fur Justiz und Verbraucherschutz), and regulatory compliance data from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry, helping global MedTech companies navigate EU MDR regulations efficiently.